GL
Gopal Laxminarayan Zanvar
About Gopal Laxminarayan Zanvar
Data last updated:
Gopal Laxminarayan Zanvar is a Director at Bayberry Pharmaceuticals Private Limited (since 2009), Director at Garron Labs Private Limited (since 2017) and Designated Partner at Bayberry Naturus Llp (since 2023). The companies operate in Pharma, Consumer Goods and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹19.67 Cr; the largest is Bayberry Pharmaceuticals Private Limited at ₹18.82 Cr (FY 2025). Earlier, Gopal Laxminarayan Zanvar was a Director at Cian Healthcare Limited (2003–2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 May 2009 | 2009 | ₹18.82 Cr (FY 2025) | Active | |
| Director | 15 Mar 2017 | 2013 | ₹85.6 Lakh (FY 2020) | Active | |
| Designated Partner | 18 Aug 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jan 2003 | 2003 | ₹62.14 Cr (FY 2024) | Under Cirp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gopal Laxminarayan Zanvar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandeep Laxminaray Zanwar | 02600119 | Bayberry Pharmaceuticals Private Limited | Director |
| Ashish Mohanlal Gundecha | 06475471 | Garron Labs Private Limited | Director |
| Rahul Manikchand Bhandari | 06566303 | Garron Labs Private Limited | Director |
| Abhishek Radhesham Bhandari | 02400628 | Bayberry Naturus Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopal Laxminarayan Zanvar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopal Laxminarayan Zanvar
Gopal Laxminarayan Zanvar currently holds 3 directorships: Bayberry Pharmaceuticals Private Limited (Director, since 07 May 2009, revenue ₹18.82 Cr (FY 2025)); Garron Labs Private Limited (Director, since 15 Mar 2017, revenue ₹85.6 Lakh (FY 2020)); Bayberry Naturus Llp (Designated Partner, since 18 Aug 2023).
Gopal Laxminarayan Zanvar was first appointed on 07 Jan 2003 as Director at Cian Healthcare Limited. The most recent appointment on record is 18 Aug 2023 at Bayberry Naturus Llp.
The 2 current companies of Gopal Laxminarayan Zanvar that report revenue have a combined latest revenue of ₹19.67 Cr: Bayberry Pharmaceuticals Private Limited ₹18.82 Cr (FY 2025); Garron Labs Private Limited ₹85.6 Lakh (FY 2020).
Gopal Laxminarayan Zanvar held 1 earlier board appointment: Cian Healthcare Limited (Director, 07 Jan 2003 to 09 Nov 2009).
The current boards of Gopal Laxminarayan Zanvar's companies include Sandeep Laxminaray Zanwar (Bayberry Pharmaceuticals Private Limited), Ashish Mohanlal Gundecha (Garron Labs Private Limited), Rahul Manikchand Bhandari (Garron Labs Private Limited), Abhishek Radhesham Bhandari (Bayberry Naturus Llp).